Animas insulin pump recall
This article was originally published in The Gray Sheet
Executive Summary
August recall of battery caps used in Animas OneTouch Ping, 2020, IR1200 and IR1250 insulin pump systems is Class I, the most serious category, FDA announces Nov. 20. The recalled battery caps were losing contact with the insulin pump's battery compartment, causing the pump to reset and temporarily lose power. This could cause either a loss of insulin delivery, resulting in hyperglycemia, or accidental overdosing by the user, resulting in hypoglycemia, FDA notes. Animas sent letters to customers from Aug. 18 to Sept. 1, which included replacement battery caps, and also sent letters to distributors